description="lightestColor"> href="http://www.sgurunews.com/emailmarketer/link.php?M=16735&N=550&L=37&F=H"> src="http://www.shareholdervision.com/guru-email/g/logo-wide.jpg"
border="0" height="77" width="700" />

You are
subscribed as Subscriber

Trade
Alert: Medizone International, Inc.
(OTCBB: MZEI)

StockGuru has issued a Trade Alert for
MZEI:

src="http://i.stockguru.com/MZEI/LogoPlaceholder.jpg" height="96"
width="489" />

Trade
Alert: Medizone’s News Today is Huge.

ONE QUOTE
FROM TODAY’S NEWS RELEASE:

“This latest round
of laboratory testing has confirmed beyond any reasonable doubt that our
enhanced AsepticSure(TM) technology can reliably achieve sterilization standards for virtually any
bacterial contaminant found in a hospital setting,” stated Dr.
Michael Shannon, Medizone’s Director of Medical Affairs.

Break-out Likely, as this news is extraordinary! face="Arial, Helvetica, sans-serif">

Do not miss the video of their Annual General Meeting:

Medizone International, Inc. Releases Video from Annual General
Meeting

href="http://www.sgurunews.com/emailmarketer/link.php?M=16735&N=550&L=735&F=H"
rel="lightbox[blah]"> src="http://www.shareholdervision.com/video/DUO.jpg" border="0"
height="273" width="485" />

href="http://www.sgurunews.com/emailmarketer/link.php?M=16735&N=550&L=735&F=H">VIEW
THE VIDEO

ABOUT
MEDIZONE INTERNATIONAL:

src="http://www.stockguru.com/l/mzei/MEDIZONE_LOGO.gif" height="88"
width="350" />
href="http://www.sgurunews.com/emailmarketer/link.php?M=16735&N=550&L=8&F=H">VIEW
THE STOCKGURU PROFILE

Medizone International, Inc. (OTCBB:
MZEI) is a research and development company
engaged in developing its AsepticSure™
technology to decontaminate and sterilize hospital surgical
suites, emergency rooms, intensive care units, schools and
other critical infrastructure. Following the current
laboratory trials, hospital mockup and hospital beta
testing will begin. Initial sales are targeted to
commence in the 4th quarter of this
year.

Profile
Facts:

style="font-size: x-large;">The Silent
Epidemic

src="http://www.stockguru.com/l/mzei/chart.gif" height="316" width="474"
/>

The chart you see above represents
the Nosocomial infections outside intensive care
units for U.S. hospitals in 2002.

As the notes that came from the source
for this chart point out, Nosocomial infections are
a huge problem in hospitals today. Although this
data is from 2002, the situation has progressively
become more serious. Here are the notes that
accompanied the chart:

“From the total number of surgical site
infections (SSI) obtained from the National Hospital
Discharge Dataset and the National Nosocomial
Infections Surveillance (NNIS) system, we subtracted
the number of SSI among newborns and adults and children
in intensive care units. The remaining SSI were among adults
and children outside of intensive care units. From
hospital-wide surveillance in NNIS, we had the
distribution of infectons by major site and
calculated the corresponding number of infections
for pneumonias (PNEU), urinary tract infections
(UTI), bloodstream infections (BSI), and other sites.”

The
Impact of Nosocomial Infections in The United States

In
2002, there were approximately 1.7 million total infections. Of
these:

• 33,269
  occurred among newborns in high-risk nurseries
• 19,059
  among newborns in well-baby nurseries
• 417,946
  among adults and children in ICUs
• 1,266,851
  among adults and children outside of ICUs.

In that
year, the estimated deaths in U.S. hospitals were 98,987. Of
these:

• 35,967
  were for pneumonia
• 30,665
  for bloodstream infections
• 13,088
  for urinary tract infections
• 8,205
  for surgical site infections, and
• 11,062
  for infections of other sites.[1]

Nosocomial
Infections are an International Problem

height="163" width="160" />

In a World Health
Organization Survey of 55 hospitals in 14
countries representing four regions, an average 8.7%
of hospital patients had nosocomial infections.

What
are some of these Infections?

Here
is a short list: C-difficile, E-coli, Pseudomonas aeruginous,
MRSA and VRE, the main causative agents of hospital derived
nosocomial infections.

How
bad are some of these?

C. Difficile

C. Difficile is the most serious cause
of antibiotic-associated diarrhea (AAD) and can lead
to pseudomembranous colitis, a severe infection of
the colon, often resulting from eradication of the
normal gut flora by antibiotics. Some estimates place
the added cost to the healthcare for C. Difficile alone
at $17.6 million daily. The CDC estimates that C. Difficile
ases in the US may reach 500,000 annually leading to potentially
30,000 deaths.

src="http://www.stockguru.com/l/mzei/mrsa.gif" />MRSA

Methicillin-resistant Staphylococcus
aureus (MRSA) is a bacterium responsible for
difficult-to-treat infections in humans. MRSA are by
definition strains of Staphylococcus aureus that are resistant
to a large group of antibiotics called the beta-lactams.
CDC reported (JAMA, 2007) that the number of serious
infections by MRSA in 2006 was close to 100,000,
with approximately 19,000 associated
deaths.

Current
Methods at Sterilization Are Not Effective Enough

The solution is quite easy in one sense.
Just eradicate the infectious diseases from the
hospital and the problem is solved. That is
prevention. The issue with this prevention is that
present methods of cleaning, disinfection and sterilization
are not effective. Current cleaning protocols for the sanitization
of hospitals have become increasingly ineffective,
resulting in an accumulation of deadly bacteria
throughout facilities.

Recent research conducted by Microsearch
Laboratories demonstrated that, after rinsing and
cleaning prior to testing using standard procedures,
a cleaning mop collected from a New York hospital
was found to have in excess of 150,000 colonies of
C. difficile. These results raise concerns about the
efficacy of current cleaning and disinfecting procedures.

To make matters even worse, non-medical
surfaces, e.g., carpets, bedding and curtains,
porous materials in ceilings, once impregnated with
highly resistant nosocomial pathogens (in
particular, spore formers such as C. difficile) cannot be
disinfected with currently available agents and processes.
Over time, these pathogens may accumulate in dangerously
high concentrations.

Current procedures for the
sensitization of hospitals have become increasingly
ineffective, resulting in an accumulation of deadly
bacteria throughout facilities.

A Solution:
Ozone is a Prime Candidate for use as a Sterilization Agent
in Medical Facilities

Many people do not realize that ozone
had a long and successful history of use as a potent
anti-bacterial, anti-fingal and anti-viral agent.
Ozone was first used as a disinfectant in 1881 by
Dr. Kellog. In 1893 Ozone was used in the Netherlands
for water purification. Presently, in excess of 3,000 municipalities
around the world use Ozone for water
purification.

Research conducted in New York City has
also demonstrated that Ozone is effective against
Legionella Bacteria, as well as pseudomonas
populations in those water purification plants. Ohio State
University (2001) demonstrated a 4 log difference in sporicidal
action of Ozone vs. Vaporized Hydrogen Peroxide (6.1 log
reduction for Ozone vs. 1.6 log reduction for VHP).
Microsearch Laboratories has demonstrated (2007)
that Ozone is 3,200 times more effective than
chlorine.

The
Leadership:

width="70" />

Edwin G. Marshall – Chairman of the
Board & Chief Executive Officer

Following a period of time in which he
unsuccessfully attempted to influence and guide
former management as a shareholder, a successful
hostile proxy action was completed on June
12,1997.

Mr. Marshall took over as Chairman of
the Board. Milton G. Adair, former President and CEO
of Gull Laboratories was appointed Chief Executive
Officer and President. Mr. Adair left the Company to
pursue other interests in 1998. Mr. Marshall then
took over the additional responsibility of Chief Executive
Officer.

Mr. Marshall attended Santa Rosa
Community College and the College of Marin, studying
fire science and business administration. Until 1978
Mr. Marshall worked in the fire service in a city
with a major chemical industrial complex, leaving with
the rank of Captain. A successful private investor since
1973 in precious metals, securities and real estate, after
leaving the fire service he went to work in the real estate
brokerage business. From 1978 until 1995 he pursued
various business interests in real estate brokerage,
a vacuum forming business in the plastics industry,
an industrial computer controls company, and an
automobile and truck dealership. Since 1997 he has
devoted all of his business time to management
responsibilities with Medizone.

height="88" width="70" />

Michael E. Shannon, M.A.,M.Sc.,M.D. -
Board Member & Director of Medical
Affairs

Dr. Shannon received his medical degree
from Queen’s University in Canada, which
included advanced training in surgery and sports
medicine. He also holds post-graduate degrees in
neurochemistry and physiology. He has been actively engaged
in applied medical research within these areas for over
27 years. He served in the Canadian Forces for 31 years
retiring at the rank of Commodore (Brigadier General
equivalent) as Deputy Surgeon General for Canada.
During the first Gulf War, Dr. Shannon served as the
senior medical liaison officer for all of the
Canadian forces. In 1996 he assumed responsibilities
within Health Canada for re-organizing the Canadian blood
system. Working with both the provincial and federal governments
he oversaw the development of a new corporate entity
dedicated exclusively to the management of blood
services in Canada. He was then appointed Director
General for the Laboratory Centre for Disease
Control, a position he held for three years. In
December 2000, Dr. Shannon left the Canadian federal
government to pursue a new career in industry. In that capacity
he simultaneously directed a phase III clinical trial in
Canada, the United States and Great Britain for an
artificial blood substitute product. Following
completion of that work he was asked to accept a
special assignment with the Canadian Federal
Government Auditor General’s office. His assignment
being to conduct a cost benefit analysis of all government
sponsored pharmacare programs and make recommendations directly
to the Parliament of Canada. His assignment and
presentation to Parliament was completed in November
2004. Dr. Shannon then served on a special
assignment to the Canadian Public Health Agency
(Center for Disease Control equivalent in the United
States) as Senior Medical Advisor. His responsibility
was to direct the rebuilding of the Emergency Medical Response
Capacity for Canada. In this regard and under his direction,
the largest emergency medical response exercise in the
history of the country, involving the overnight
construction of a mobile hospital, hundreds of
doctors and thousands of patients, was successfully
held in Toronto in December of 2007.

Dr. Shannon has been actively engaged in
medical bio-oxidative (O3 based), research since
1987 and was directly responsible for the first
human clinical trial to have ever been approved in
North America which examined the efficacy of O3 delivered
via minor autohemotherapy in the treatment of AIDS. He was
also responsible for several primate studies utilizing O3
involving scientists from various departments within the
Canadian Federal Government, as well as senior
investigators from Medizone International and
Cornell University. Dr. Shannon has served as the
Senior Medical Advisor to Medizone International
since 2002. In August of 2008 he accepted a position
on the Board of Directors of Medizone International
and assumed responsibility for medical affairs. In October
2008, he was additionally appointed the President of the
Canadian Foundation for Global Health.

height="88" width="70" />

Richard Garret Solomon – Director and
Executive Officer

Mr. Solomon first invested in Medizone
in 1992. In 1995, Medizone New Zealand Limited (a
partially owned subsidiary of Medizone
International) was formed as a 50/50 joint venture. In January
1996, until February 1997, Mr. Solomon was a Director of
Medizone International, Inc. and has rejoined the board
as of May 1, 2000.

Mr. Solomon received a Bachelor of
Commerce (University of Otago), Diploma of Business
and Industrial Administration (University of
Auckland), and is an Associate Chartered Accountant.
His career has been in business and investment, and for
20 years he developed and ran his own private hospital operating
company, Haven Care Hospitals Limited. He was a longstanding
Board member and President of the New Zealand
Hospitals Association. He lead the establishment of
The New Zealand Council of Healthcare Standards,
Inc.

width="70" />

Daniel D. Hoyt – Board
Member

Mr. Hoyt graduated from Indiana
University with a Bachelor of Science degree in
General Business Administration in 1962. For the
past 31 years, he has been involved in the life
insurance and group benefits industry achieving both industry-wide
and national company recognition for production and
mentorship. Mr. Hoyt takes great pride in the
relationships he has built through consultations
with his business clients that range from large
public companies to small private businesses.
Throughout his career, he has served as mentor to many other
entrepreneurs. Mr. Hoyt previously worked 7 years as an
account executive at Merrill Lynch and as Chief Executive
of two and Vice President of one Chamber of Commerce in
Indiana. In addition to his board position with Medizone
International, Mr. Hoyt is the Chairman of the Board
of Biological Systems, Inc., a bio-cleansing,
microbial remediation system dealing with natural
animal fats and oil-based materials.

Mr. Hoyt is and has been very active in
his community and church. These activities and
positions include: current board member of the
Indiana University Cancer Center Development Board;
former board member and chair of Saint Mary of the Woods
College, Terre Haute, IN; board chair of Our Lady of Fatima
Retreat Center; twice chair of the Parents Association of
Ball State University. Numerous other board and leadership
positions include St. Elizabeth Home for Unwed
Mothers, past president of Indianapolis Sierra Club,
Prevent Blindness of Indiana; Indianapolis Business
Development Foundation and Christamore Settlement
House. He is currently chair of the Rebuild My
Church Board of Visitors of Marian College, an
active member of Immaculate Heart of Mary Catholic Church
and a founding member of Pink Ribbon Connection, a newly
formed group serving the needs of breast cancer patients
and survivors in central Indiana (he is a 10-year
survivor).

height="88" width="70" />

Steve M. Hanni – Chief Financial
Officer

Mr. Hanni has served as Medizone
International’s Chief Financial Officer since April
2, 2002.

Additionally, Mr. Hanni is the Audit
Partner-in-Charge and Vice-President of the
accounting firm, Stayner, Bates & Jensen, P.C.,
located in Salt Lake City, Utah. He was formerly a partner
with the accounting firm, HJ & Associates, LLC, also
located in Salt Lake City. HJ & Associates serves as
the Company’s audit firm.

Mr. Hanni has worked closely with many
different types of companies and organizations and
has extensive auditing and consulting experience in
the following industries: Mortgage Banking,
Construction, Manufacturing, Oil and Gas companies, Retail,
High Technology, Non-profit and Pension Plans.

In addition, Mr. Hanni has significant
experience with Securities and Exchange Commission
listed companies, including registration statements,
public offerings and audits as well as providing
management advisory services.

Contact
information:

Medizone International, Inc. (OTC:
MZEI)

Web:
href="http://www.sgurunews.com/emailmarketer/link.php?M=16735&N=550&L=62&F=H">http://www.medizoneint.com

Telephone:
415-868-0300

Fax:
415-868-2344

Address:

PO Box 742
Stinson Beach, CA 94970

Live
Twitter Alerts All Market Day

Our
Twitter Feed includes all live posts from StockGuru.com.

href="http://www.sgurunews.com/emailmarketer/link.php?M=16735&N=550&L=141&F=H"> src="http://www.stockguru.com/l/twitter-163w.gif" border="0" />

Featured
on StockGuru

While
we cover many companies, here are our current featured profiles
on StockGuru:

href="http://www.sgurunews.com/emailmarketer/link.php?M=16735&N=550&L=8&F=H"
style="color: #576164">Medizone International Inc.
(OTCBB: MZEI)

href="http://www.sgurunews.com/emailmarketer/link.php?M=16735&N=550&L=175&F=H"
style="color: #576164">Skinvisible, Inc.
(OTCBB: SKVI)

href="http://www.sgurunews.com/emailmarketer/link.php?M=16735&N=550&L=140&F=H"
style="color: #576164">DecisionPoint Systems, Inc.
(OTCBB: DNPI)

href="http://www.sgurunews.com/emailmarketer/link.php?M=16735&N=550&L=666&F=H"> src="http://www.boldstocks.com/images/BOLD-163-178.gif" border="0"
height="178" width="163" />

href="http://www.sgurunews.com/emailmarketer/link.php?M=16735&N=550&L=3&F=H"
style="color: #576164"> href="http://www.sgurunews.com/emailmarketer/link.php?M=16735&N=550&L=204&F=H"> src="http://www.stockguru.com/l/china/china-163-wide.gif" border="0"
height="155" width="163" />

href="http://www.sgurunews.com/emailmarketer/link.php?M=16735&N=550&L=1&F=H"
style="color: #576164">

StockGuru
Spotlight Alerts

Here
are our latest Spotlight Alerts. Note that we typically
do NOT email these to members. You must visit the site at href="http://www.sgurunews.com/emailmarketer/link.php?M=16735&N=550&L=4&F=H"
style="color: #576164">THIS LINK to keep up to
date; or you may subscribe to href="http://www.sgurunews.com/emailmarketer/link.php?M=16735&N=550&L=2&F=H"
style="color: #576164">THIS RSS
FEED.

Suggest
a Client:

Do you
know a great company that simply must be featured on
StockGuru or Shareholder Vision?

Suggest it
to us.

Email: href="mailto:john@stockguru.com" style="color:
#576164">john@stockguru.com
Tel: (469) 252-3031.